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Background: PAK1 is phosphorylated and
activated by the protein kinase CK2 in response to
EGF.
Results: Upon EGF stimulation, CKIP-1 recruits
CK2 to PAK1 in membrane ruffles in a PI3Kdependent manner.
Conclusion: PI3K activates PAK1 at the plasma
membrane by promoting CK2 phosphorylation of
PAK1 via CKIP-1.
Significance: This is the first evidence of spatial
regulation of PAK1 activity.

Consistently, we observe that PAK1 mediates
phosphorylation and modulation of the activity
of p41-Arc, one of its plasma membrane
substrate, in a fashion that requires PI3K and
CKIP-1. Moreover, CKIP-1 knockdown or
PI3K inhibition suppresses PAK1-mediated cell
migration and invasion, demonstrating the
physiological significance of the PI3K-CKIP-1CK2α-PAK1 signaling pathway. Taken
together, these findings identify a novel
mechanism for the activation of PAK1 at the
plasma membrane, which is critical for cell
migration and invasion.
________________________________________

ABSTRACT
Upon growth factor stimulation, PAK1 is
recruited to the plasma membrane and
activated by a mechanism that requires its
phosphorylation at S223 by the protein kinase
CK2.
However, the upstream signaling
molecules that regulate this phosphorylation
event are not clearly defined. Here, we
demonstrate a major role of the CK2αinteracting protein CKIP-1 in activation of
PAK1. CK2α, CKIP-1 and PAK1 are
translocated to membrane ruffles in response to
the epidermal growth factor (EGF), where
CKIP-1 mediates the interaction between
CK2α and PAK1 in a PI3K-dependent manner.

PAK1, a major downstream effector of the
Rho-family GTPases Cdc42 and Rac1, plays a
critical role in the regulation of cell morphology
and motility (1). In its inactive state, PAK1 forms
a trans-inhibited dimer, where the N-terminal
autoinhibitory domain (AID) on one PAK1
molecule binds to and blocks the C-terminal
catalytic domain of its counterpart (2,3). This
autoinhibition is relieved through binding of
GTPases to the PBD (p21-binding domain)/CRIB
(Cdc42/Rac-interacting) domain that partially
overlaps with AID, leading to autophosphorylation
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PI3K Regulation of PAK1
We have recently demonstrated that CK2
catalyzes phosphorylation of PAK1 at S223,
which is critical for the activation of the kinase
(26). Here, we show evidence that CKIP-1
appears to recruit CK2α to PAK1 in response to
EGF in a PI3K-dependent manner. Consequently,
inhibition of either CKIP-1 or PI3K activity blocks
PAK1-mediated actin cytoskeleton dynamics and
cell migration. These results demonstrate the role
of CKIP-1 in EGF-induced activation of PAK1,
providing a novel regulatory mechanism for PAK1
signaling.
EXPERIMENTAL PROCEDURES
Cell cultures—The human prostate cancer PC3
cells were maintained in RPMI 1640 containing
10% fetal bovine serum (FBS) and 1%
penicillin/streptomycin in a humidified incubator
(37°C and 5% CO2). The benign prostate epithelial
RWPE-1 cells were cultured in keratinocyte
serum-free medium (K-SFM) containing 5 ng/ml
of epidermal growth factor (EGF) and 50 µg/ml of
bovine pituitary extract (BPE). CKIP-1
knockdown PC3 and RWPE-1 cells were grown in
suitable medium containing 2 µg/ml of puromycin.
Lentiviral
infection—Standard
lentiviral
transduction was performed as described
previously (27). In brief, lentiviral transduction
was used for CKIP-1 knockdown and GFPPAK1WT overexpression in prostate cancer cells
(PC3 and RWPE-1). Lentiviral short hairpin
RNAs (shRNAs) specific for CKIP-1 were
purchased from Sigma-Aldrich (sh1, TRCN00001
-65913; sh2, TRCN0000165914). For viral
production, 293T cells were cotransfected with
pLKO.1-shNT or pLKO.1-CKIP-1 specific
shRNAs, and packaging and envelope vectors
psPAX2
and
pCMV-VSV-G
using
the
LipofectamineTM LTX transfection reagent
(Invitrogen). Transfection was performed as
described previously (27).
Western blot analysis—Whole cell extracts
were prepared in RIPA buffer (50 mM Tris pH
7.4, 15 mM Nacl, 1% NP-40, 0.5% Sodium
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at specific sites, including Thr-423 within the
activation loop, and consequent activation of
PAK1 (4). PAK1 is recruited to the plasma
membrane via the SH3-containing proteins Nck
and Grb2 upon stimulation by growth factors (59), leading to efficient activation of PAK1.
CK2 (Casein Kinase 2) is a serine/threonine
kinase that regulates a broad range of biological
processes, including cell growth and survival, gene
expression, and actin cytoskeleton organization
(10,11). CK2 is a tetramer composed of two α
catalytic subunits and two β regulatory subunits,
but the precise mechanism of its regulation is not
fully understood. Emerging evidence shows that,
in cancer cells, CK2 is frequently elevated and
translocated into the nucleus to regulate gene
expression (12,13) and also targeted to the plasma
membrane to regulate actin cytoskeleton
organization by acting on proteins such as WASP
(14), CRN2 (15), myosin-9 (16) and WAVE2 (17).
Therefore, the regulated translocation of CK2 to
different cellular compartments may be critical for
its functional regulation (11).
The Pleckstrin homology (PH) domaincontaining protein CKIP-1, identified as a CK2α
interacting protein (18), recruits CK2α to the
plasma membrane (19). Accumulating evidence
indicates that CKIP-1 is involved in various
cellular processes including cell proliferation,
differentiation, morphology and migration in
various human cell lines including human
osteosarcoma U2-OS and macrophage (20-22).
CKIP-1 binds to multiple proteins (e.g., CK2α,
CPα, Akt, C-Jun ATM, IFP/Nmi and Smurf1) via
its PH domain, implicating its role as a scaffold
protein in various signaling pathways (23). Of
note, CKIP-1 appears to associate with the plasma
membrane through binding to phosphoinositides
and to regulate muscle differentiation in mouse
myoblast C2C12 cells (24) as well as myoblast
fusion in mouse and zebrafish, in PI3K-dependent
fashion (25). These observations have raised the
possibility that CKIP-1 may serve as a key
controller of cellular processes regulated by PI3K.

PI3K Regulation of PAK1

RESULTS
PAK1, CK2α and CKIP-1 are recruited to
membrane ruffles in response to EGF—PAK1
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Cell migration and invasion assays—For the
wound-healing migration assay, PC3 cells were
seeded at 70% confluence into 6-well culture
dishes and, 24 h later, infected with CKIP-1specific or control shRNA lentivirus. When the
cells grew to confluence, scratch wounds were
made on the monolayers using sterile 200 µl
pipette tips. After 24 h incubation, the wounded
monolayers were washed gently twice with 1X
PBS to remove the detached cells and replenished
with fresh media. The cells were fixed with 4%
paraformaldehye for 30 minutes and then
photographed. Wound areas were measured using
ImageJ software.
Cell invasion assay was
performed using the cell invasion kit (Transwell
Boyden’s chamber with TranswellTM Permeable
Support Inserts Coated with Cultrex® BME
(basement membrane extract, Corning Costar)
according to the manufacture’s instruction.
Briefly, serum-starved PC3 and RWPE-1 (2 × 105
cells/well) cells were added to the upper chamber,
whereas suitable media containing 10% FBS was
added to the lower chamber and cultured in an
incubator for 24 h. Nonmigrating cells were gently
removed from the upper surface of the filter with a
cotton swab; migrating cells which were attached
to the lower surface of the filter were fixed and
stained with hematoxylin for counting.
Soft agar colony forming assay—Anchorageindependent growth was determined by examining
cell growth in soft agar. RWPE-1 cells (3 × 104)
were seeded in 0.3% agar on top of a base layer of
0.6% agar containing K-SFM (keratinocyte serumfree medium) and 1 μg/ml of puromycin. The cells
were placed in a 37°C, 5% CO2 incubator. After 2
weeks, colonies were stained with crystal violet
(0.05%) and counted. Colonies were counted
under a microscope (Nikon Eclipse Ti; Melville,
NY). All assays were performed in triplicate.

deoxycholate, 0.1% SDS) with protease inhibitors
(28). For immunoprecipitation, cells were lysed
lysed in IP lysis buffer (25 mM HEPES pH7.4,
150 mM NaCl, 1 mM EDTA, 0.5% Triton X-100)
and mixed with protein G-Sepharose beads (GE
healthcare) prebound to mouse normal IgG and
anti-GFP (Santa Cruz) for 4 h with rotation at 4°C.
Pull-down beads were washed four times with IP
wash buffer (25 mM HEPES pH7.4, 1 M NaCl, 1
mM EDTA, 0.5% Triton X-100). Plasma
membrane fractions were prepared using MemPERTM Eukaryotic Membrane Protein Extraction
Reagent Kit (Thermo Scientific) following the
manufacture`s protocols. Protein concentration
was quantified using Bradford to calculate the
ratio of each sample volume. The protein samples
were resolved on a 10% SDS–PAGE gel and
transferred to a nitrocellulose membrane.
Antibodies used in this study include antiphospho-PAK1S223 (26), anti-phospho-PAK1S144,
anti-PAK1, anti-Na/K-ATPase (Cell Signaling),
anti-CK2α, anti-GFP (Santa Cruz), anti-α-Tubulin
(Neo Markers), anti-phospho-p41-ArcT21 (ECM
Biosciences) and anti-CKIP-1 (Sigma-Aldrich)
antibodies.
Immunofluorescence staining—Cells were
grown on glass coverslips and transfected with
either control (NT) or CKIP-1 specific shRNA
constructs. After 24 h, cells were washed twice in
cold PBS before fixation with 4% PFA for 10 min
at room temperature (RT). After fixation, the cells
were washed three times with PBS for 5 min each
and incubated with the blocking buffer containing
5% BSA and 5% normal goat serum. Coverslips
were incubated with primary antibodies overnight
at 4°C or with Rhodamine-labeled Phalloidin in
PBS for 30 min at room temperature. After
washing three times with PBS, cells were treated
with secondary antibodies for 1 h. DNA was
stained with 0.1 ug/ml DAPI (4', 6-diamidino-2phenylindole) in PBS for 1 min. Cells were
mounted in a mounting medium (KPL) and
imaged on an Olympus IX71 inverted microscope
(Olympus Imaging America Inc).

PI3K Regulation of PAK1
inactive (PAK1S144) and unable to phosphorylate
its substrate p41-Arc at T21 (p41-ArcT21) (Fig.
2D). Consequently, CKIP-1 silencing decreases
the colocalization of CK2α with an active form of
PAK1 (phospho-PAK1S144) (Fig. 2E) and that of
F-actin with either phospho-PAK1S144 (Fig. 2F) or
phospho-p41-ArcT21 (Fig. 2G) to the cell
periphery. Collectively, these results indicate that
CKIP-1 functions to promote CK2-dependent
phosphorylation and activation of PAK1 by
recruiting CK2α to PAK1 to the plasma
membrane.
Expression of a constitutively active PAK1
(PAK1S233E) bypasses the requirement for CKIP-1
in PAK1-induced cell polarity and migration—
Our recent work shows that CK2 phosphorylates
S223 of PAK1, and that a phosphomimetic
mutation at S223 (S to E) generates a
constitutively active PAK1 (26). We find that,
upon EGF treatment, PAK1 is recruited to the
plasma membrane (Fig. 1A) and phosphorylated at
S223 (Figs. 3A and 3B). To understand further
CKIP-1 regulation of PAK1, we infected CKIP-1
knockdown PC3 cells with a lentivirus expressing
GFP-PAK1 and examined the activity and
localization of PAK1 using anti-phospho-specific
PAK1 (S223) antibody. Western blot analysis
shows that CKIP-1 silencing decreases S223
phosphorylation of PAK1 (Fig. 3C). In addition,
fluorescence microscopy analysis shows that
CKIP-1 knockdown results in decreased
phosphorylation at S223 (Fig. 3D, middle) and,
consequently, in loss of cell polarity (Fig. 3D,
CKIP-1), and that the polarization defect of CKIP1 knockdown cells (Fig. 2, shCKIP-1) is partially
rescued by overexpression of GFP-PAK1 (Fig. 3E,
shCKIP-1).
To examine the physiological significance of
CKIP-1 regulation of PAK1 activity, we
investigated whether PAK1-induced cell migration
and invasion are affected by CKIP-1 knockdown.
Wound healing assays show that CKIP-1 silencing
inhibits migration of PC3 cells expressing wild

CKIP-1 mediates EGF-induced PAK1
interaction with CK2α—To gain more insights
into the role of CKIP-1 in EGF-induced PAK1
activation, we assessed the effect of CKIP-1
knockdown on the interaction between CK2α and
PAK1. Upon EGF treatment in PC3 cells, PAK1
and CK2α are colocalized and interact with each
other at the plasma membrane (Figs. 2A and 2C).
However, this interaction is greatly reduced by
CKIP-1 knockdown (ShCKIP-1 in Figs. 2A and
2C). This is perhaps because CKIP-1 silencing
results in decreased localization of CK2α to the
plasma membrane (Fig. 2B), which renders PAK1
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regulates cell polarity and migration in response to
growth factors by modulating the actin
cytoskeleton (29-31).
Immunofluorescence
microscopy indicates that EGF induces the
formation of membrane ruffles at the leading edge
of polarized PC3 prostate cancer cells (Fig. 1A, Factin) by promoting the recruitment of PAK1,
CK2α, and CKIP-1 to membrane ruffles (Fig. 1A).
Increased PAK1 activity is associated with autophosphorylation of specific sites including S144
(32). Activated PAK1 phosphorylates T21 of p41Arc, a subunit of the human Arp2/3 complex, at
the plasma membrane (33). Thus, PAK1 activity
can be assessed by the phosphorylation state of
S144 of PAK1 (PAK1S144) and T21 of p41-Arc
(p41-ArcT21). EGF treatment does not affect the
expression of CK2α, CKIP-1, or PAK1, but does
increase phosphorylation of PAK1S144 and p41ArcT21 (Fig. 1B). Given that CKIP-1 interacts with
CK2α (19), we addressed the role of CKIP-1 in
CK2 activation of PAK1. CKIP-1 does not
regulate the expression of CK2α or PAK1 (Fig.
1C); instead, it mediates the EGF-induced
recruitment of CK2α to membrane ruffles (Fig.
1D).
It is of note, however, that PAK1
localization to the plasma membrane is not
regulated by CKIP-1 (Fig. 1D). Thus, CKIP-1
seems to play a key role in EGF-induced PAK1
activation by recruiting CK2α to the plasma
membrane.

PI3K Regulation of PAK1
(Fig. 5A) and inhibit the colocalization of CKIP-1
with either CK2α (Fig. 5B) or PAK1 (Fig. 5C) and
that of PAK1 with CK2α (Fig. 5D). Thus, PI3K
may regulate the CKIP-1-mediated interaction
between CK2α and PAK1 by controlling the
plasma membrane localization of CKIP-1.

type GFP-PAK1 by 70%, but this inhibitory effect
is not observed in PC3 cells expressing GFPPAK1S223E (Fig. 3F). Similarly, cell invasion
assays using Transwell Boyden’s chamber system
indicate that invasion of PC3 cells expressing
GFP-PAK1 is inhibited 70 – 80% by CKIP-1
knockdown, and that, however, CKIP-1 inhibition
does not significantly reduce the invasiveness of
PC3 cells expressing GFP-PAK1S223E (Fig. 3G).
These results indicate that CKIP-1 knockdown
suppresses PAK1-mediated cell migration and
invasion.
The CKIP-1-mediated interaction between
CK2α and PAK1 is regulated by PI3K—CKIP-1,
as a Pleckstrin Homology domain-containing
protein, is recruited by phosphatidylinositol 3‐
phosphate (PI3P) to the plasma membrane in a
PI3K (phosphatidylinositol 3‐kinase)-dependent
manner (24). This notion is further supported by
the finding that the inhibition of PI3K signaling
reduces plasma membrane localization of CKIP-1
(34). An early study showed that PAK1 regulates
the invasiveness of breast cancer cells via PI3K
signaling (35). These observations suggest that
PI3K regulates PAK1 activity through CKIP-1.
To address this idea, we treated PC3 cells with the
PI3K inhibitors LY294002 and wortmannin and
examined the subcellular localization of CKIP-1,
CK2α and PAK1.
Both LY294002 and
wortmannin inhibit the EGF-induced membrane
localization of CKIP-1 (Fig. 4A), CK2α and PAK1
(Figs. 4D and 4E), and this may be associated with
a decrease in the formation of membrane ruffles
(Figs. 4A, 4D and 4E). In agreement, Western blot
analysis demonstrates low levels of CKIP-1 and
CK2α at the plasma membrane (Fig. 4B) and
decreased PAK1 activity, as measured by the
phosphorylation of PAK1S144 and p41-ArcT21 (Fig.
4C), in PC3 cells treated with LY294002 or
wortmannin.
Consistently, the PI3K inhibitors LY294002
(Fig. 5) and wortmannin (data not shown) disrupt
the interaction of PAK1 with CK2α and CKIP-1

CKIP-1 is required for PAK1-mediated
malignant transformation of the benign prostate
RWPE-1 cells— Overexpression of PAK1 induces
malignant transformation of the benign prostate
RWPE-1 cells in vitro and in vivo (26). Given that
CKIP-1 regulates PAK1 activity (Figs. 2 and 3),
we examined the effects of CKIP-1 silencing on
the PAK1-mediated migration and invasion of
RWPE-1 cells. Overexpression of PAK1 induces
the formation of membrane ruffles, which,
however, is inhibited by CKIP-1 knockdown (Fig.
7A). As observed in PC3 cells (Fig. 3), CKIP-1
knockdown decreases phosphorylation of PAK1
(Fig. 7B) and suppresses PAK1-induced migration
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Expression of a constitutively active PAK1
(PAK1S233E) bypasses the requirement for PI3K in
the EGF-induced activation of PAK1—Given that
PI3K acts as an activator of PAK1 (Fig. 4 and 5),
we examined the effects of PI3K inhibition on the
CK2-mediated phosphorylation and activation of
PAK1. Akt is phosphorylated at S473 by PI3K,
thus this phosphorylation is used as a biochemical
marker for PI3K activation (36). Our results show
that LY294002 inhibits the phosphorylation of
AktS473, PAK1S223 and p41-ArcT21 (Fig. 6A) and the
EGF-induced colocalization of phospho-PAK1S223
and phospho-p41-ArcT21 to the membrane ruffles
(Fig. 6B).
However, expression of the
constitutively active PAK1 (PAK1S223E) induces
the phosphorylation of p41-ArcT21 (Fig. 6C) and
PAKS144 (Fig. 6D) even in LY294002-treated PC3
cells. Furthermore, the migration defect of these
cells is rescued by the expression of GFPPAK1S223E (Fig. 6E). Thus, these observations
indicate that PI3K is required for PAK1-mediated
cell migration.

PI3K Regulation of PAK1

DISCUSSION
PAK1 is a pluripotent kinase that regulates
numerous cellular processes, including cell growth
and proliferation, actin cytoskeleton organization,
cell cycle and apoptosis (37-40). It remains
unknown, however, how PAK1 can perform such
diverse functions remains unknown. It has been
suggested that the fine control of localization and
activation of PAK1 may be the mechanism used
by the cell to activate the right PAK1-dependent
pathway according to the cell cycle status or in
response to extracellular stimuli (39). An early
study showed that PI3K activation induces PAK1
kinase activity in a Cdc42/Rac1 or an Aktindependent mechanism (41). However, the
underlying mechanism remains unknown. In this
study, we establish the role of CKIP-1 in the PI3K
activation of PAK1 in response to EGF. CKIP-1
was originally identified as a CK2α-interacting
protein. However, it has not been demonstrated
whether CKIP-1 is involved in phosphorylation of
CK2 substrates (18,19,23). Our data show for the
first time that CKIP-1 delivers CK2α to PAK1 in
response to EGF, and that this process is regulated
by PI3K, demonstrating a mechanistic link
between CK2 and PI3K signaling.
Emerging evidence indicates that PI3K
mediates plasma membrane association of CKIP-1
(23). CKIP-1 exhibits a very broad spectrum of
binding to phosphoinositols through its PH domain
(19). In myoblast C2C12 cells, CKIP-1 binds to
PI3P (phosphoinositol-3-phosphate) at the plasma
membrane in response to insulin and regulates
muscle differentiation; however, PI3K inhibition
or coexpression of PI3K (∆p85), a dominant
negative mutant of PI3K, leads to nuclear
accumulation of CKIP-1 (24). CKIP-1 bound to
phosphoinositides via its PH domain regulates cell
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morphology and lamellipodia formation by
recruiting the Arp2/3 complex to the plasma
membrane (25). Subcellular localization of CKIP1 is dependent on the cell type. CKIP-1 localizes
in the nucleus in osteosarcoma Saos-2, mouse
preosteoblastic MC-3T3 and rodent fibroblast Rat1 cells, but is also found at the plasma membrane
in monkey kidney COS-7 cells (18). Therefore, it
has been suggested that CKIP-1, as a scaffolding
protein, may shuttle between the nucleus and the
plasma membrane and redistributes signaling
complexes between these two compartments in a
PI3K-dependent manner (24).
An intriguing finding in the present study may
be that PI3K tightly controls PAK1 activity by
regulating EGF-induced localization of CK2α and
PAK1 to the plasma membrane. We show that
CKIP-1, CK2α and PAK1 are recruited to the
leading edge of the cells in response to EGF (Fig.
1), and that this process is regulated by PI3K (Fig.
4). Accordingly, PAK1 phosphorylation of one of
its plasma membrane substrates p41-ArcT21 occurs
in PI3K-, CKIP-1- and CK2α−dependent manners.
These findings reveal a novel signaling pathway
by which PI3K activates PAK1 in response to
EGF (PI3K CKIP-1CK2 PAK1). Our data
provide evidence that PI3K regulates localization
of PAK1 to the membrane ruffles (Figs. 4D and
4E), but the underlying mechanism is unknown.
PAK1, like CKIP-1, associates with the plasma
membrane through phosphoinositides (42), and
this process may be regulated by Nck and Grb2
(8,9). PI3K/Akt also appears to regulate plasma
membrane localization of PAK1; a mutation of the
Akt phosphorylation site in PAK1 blocks PAK1
activation and inhibits PAK1 redistribution in
response to chemoattractant stimulation, but
LY294002 treatment results in a rapid loss of cell
polarity and PAK1 redistribution (43). Thus, these
observations are consistent with our results that
PI3K regulates localization of PAK1 to the plasma
membrane.
PAK1 acts as a convergence point of many
signaling
pathways
that
are
frequently

(Fig. 7C) and proliferation (Fig. 7D) of RWPE-1
cells. These results suggest that CKIP-1 regulates
prostate cancer migration and proliferation by
modulating PAK1 activity.

PI3K Regulation of PAK1
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PAK1 is the major isoform of PAKs expressed
in most cancers (38,48) and its expression is
sufficient to promote prostate tumor growth (49).
Given that S223 of PAK1 is not conserved in other
PAK family members, CK2-mediated S223
phosphorylation is considered a unique regulatory
mechanism for PAK1 activation (26). Activation
of oncogenic kinases by elevated expression is a
common feature of human primary tumors.
However, there is no significant difference in
PAK1 expression between prostate normal and
malignant tissues (GeneCards, www.genecards.
org). Instead, blocking S223 phosphorylation leads
to growth inhibition of prostate cancer PC3 cells
(26). Therefore, PI3K-, CKIP-1-, and CK2dependent phosphorylation of PAK1 plays a key
role in malignant transformation of prostate cells.
This concept is also supported by the observation
that the silencing of CKIP-1 by shRNA inhibits
PAK1-mediated migration and invasion of benign
prostate epithelial RWPE-1 cells (Fig. 7). Aberrant
activation of growth factor receptor signaling is
associated with human cancer (38), and the EGF
receptor is overexpressed in PC3 cells (50). These
observations strengthen the view that CKIP-1mediated CK2 phosphorylation of PAK1, which is
triggered by PI3K activation, may be the principal
mechanism for the activation of PAK1 in prostate
cancer cells.

dysregulated in human cancers and thus is
activated by various signaling factors, including
p21 GTPases, thrombin, growth factors and
hormones (38,40). Phosphorylation of PAK1 at
T423 in the kinase activation loop is crucial for
enzymatic activity. Binding of GTPases and lipids,
such as sphingosines, to PAK1 results in exposure
of the activation loop of the kinase domain (44),
making it accessible for T423 phosphorylation by
3-phosphoinositide-dependent kinase 1 (PDK1)
(45). It should be noted that PDK1
phosphorylation of PAK1 is not blocked by
pretreatment with PI3K inhibitor wortmannin or
when PDK1 was mutated to prevent
phosphatidylinositol binding, indicating that this
process is independent of PI3K activity (46).
Therefore, T423 phosphorylation by PDK1 may
be necessary but not sufficient for the activation of
PAK1. Our results have demonstrated that CK2
phosphorylation of S223 is crucial for activation
of PAK1 (26), and that this process is regulated by
PI3K (this study). The kinase activity of a
constitutively active PAK1 (PAK1H83,86L),
postulated to mimic GTPase-induced structural
changes (47), requires phosphorylation of S223,
suggesting that S223 may become available for
phosphorylation by CK2 after the conformational
change (26). Therefore, PI3K-dependent, CKIP-1mediated recruitment of CK2α to the plasma
membrane is essentially required for the activation
of PAK1.

PI3K Regulation of PAK1
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FIGURE LEGENDS
FIGURE 1. PAK1, CK2α and CKIP-1 are recruited to membrane ruffles in response to EGF. PC3
cells were serum-starved for 24 h and then incubated in the absence (-) or the presence (+) of EGF (100
ng/ml) for 1 h. A, Fluorescence microscopy images of PC3 cells stained with rhodamine-labeled
phalloidin (red) or an antibody to PAK1, CK2α or CKIP-1 (green) (top) and quantification of plasma
membrane (PM) localization of PAK1, CK2α and CKIP-1 (bottom). B, Whole-cell lysates of PC3 cells
were analyzed by Western blotting using antibodies to the indicated proteins. C, Total lysates of PC3 cells
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PI3K Regulation of PAK1
with (Sh) or without (NT) CKIP-1 knockdown were analyzed by Western blotting using anti-CK2α or
anti-PAK1 antibody. D, Fluorescence microscopy images of CKIP-1 knockdown PC3 cells stained with
anti-CK2α or anti-PAK1 antibody (left) and quantification of PM localization of PAK1 and CK2α
(right). The quantitative evaluation of the immuno-staining patterns was performed on at least 1000 cells
per sample, in at least three independent experiments, and the results were expressed as the percentages of
cells with PM localization of the respective proteins (A and D). ***P <0.001.

FIGURE 3. Expression of a constitutively active PAK1 (PAK1S233E) bypasses the requirement for
CKIP-1 in EGF-induced cell polarity and migration. PC3 cells were serum-starved for 24 h and then
stimulated by EGF (100 ng/ml) for 1 h. A, PC3 cells were stained with anti-phospho-PAK1S144 antibody
(red). B, Quantification of cells stained with anti-phospho-PAK1S223 antibody. Cells with plasma
membrane (PM) localization of phospho-PAK1S144 were quantified as described above (Fig. 1). ***P
<0.001. C, Western blot analysis of S223 phosphorylation of PAK1. Whole cell lysates of CKIP-1
knockdown (CKIP-1) and control (NT) PC3 cells expressing GFP-PAK1 were blotted with antibodies to
the indicated proteins. D, PC3 cells stimulated by EGF were stained with anti-phospho-PAK1S223
antibody (green) and rhodamine-labeled phalloidin (red). E, Immunofluorescence analysis of the
localization of GFP-PAK1 and phospho-PAK1S223. PC3 cells expressing GFP-PAK1 were stained with
anti-phospho-PAK1S223 antibody (middle). DNA was stained with DAPI (blue) in D and E. F, Wound
healing assay of PC3 cells expressing GFP-PAK1 or GFP-PAK1S223E (left). The results were expressed as
the percentages of the remaining area as determined by normalizing the area of wound after 24 h (black
bars) to the initial wound area at 0 h (white bars, set to 100%) (left). Each bar represents the mean ± s.e
of five fields counted (***, P<0.001) (right). G. Invasion assay of PC3 cells expressing GFP-PAK1Wt or
GFP-PAK1S223E. Cell invasiveness was assessed using a Transwell Boyden chamber assay (top). The
invasion rate was determined by counting the number of cells having migrated through the membrane into
the lower chamber, and the results were expressed as a percentage relative to control cells (shNT cells
expressing GFP-PAK1, set to 100%). Each bar represents the mean ± s.e of five fields counted (***,
P<0.001) (bottom).
FIGURE 4. PI3K regulates the localization of CKIP-1 to the plasma membrane. PC3 cells were
serum-starved 24 h, stimulated by EGF (100 ng/ml) for 1 h, and then treated with LY294002 (25 µM) for
4 h or wortmannin (WT, 100 nM) for 1 hr. A, Fluorescence microscopy images of PC3 cells stained with
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FIGURE 2. CKIP-1 recruits CK2α to PAK1 to membrane ruffles in response to EGF. PC3 cells
with (Sh) or without (NT) CKIP-1 knockdown were serum-starved for 24 h and then treated with EGF
(100 ng/ml) for 1 h. A, PC3 cells were costained with anti-CK2α (green) and anti-PAK1 (red) antibodies.
B, The plasma membrane-enriched fraction of PC3 cells was analyzed by Western blotting using
antibodies to CKIP-1, CK2α or PAK1. The plasma membrane Na+/K+-ATPase was used as a loading
control. C, GFP-PAK1 expressed in PC3 cells (a ShNT and two Sh-CKIP-1s) was immunoprecipitated
using anti-GFP antibody (IP), and blots were probed with antibodies to the indicated proteins. D, Wholecell lysates of PC3 cells with (Sh) or without (NT) CKIP-1 knockdown were blotted with antibodies to
the indicated proteins. E, Colocalization of CK2α (green) with an activated form of PAK1, PAK1S144
(pS144, red) in PC3 cells. F and G, PC3 cells were costained with rhodamine-labeled phalloidin (red)
and either anti-phospho-PAK1S144 antibody (green) (F) or anti-phospho-p41-ArcT21 antibody (green) (G).
DNA was stained with DAPI (blue) in A, E, F and G.

PI3K Regulation of PAK1
anti-CKIP-1 antibody (top) and quantification of plasma membrane (PM) localization of CKIP-1 as
described in Fig. 1 (bottom). B, The plasma membrane-enriched fraction of PC3 cells was analyzed by
Western blotting using antibodies to CKIP-1, CK2α and PAK1. Na+/K+-ATPase was used as loading
control. D, PAK1 activity in PC3 cells treated with (+) or without (-) LY294002 or wortmannin. C.
Western blot analysis of the phosphorylation of PAK1S144 and p41-ArcT21. Whole-cell lysates were blotted
with antibodies to the indicated proteins. D and E, PC3 cells were costained with rhodamine-labeled
Phalloidin (red) and either anti-CKIP-1, CK2α or PAK1 antibody (green). DNA was stained with DAPI in
D and E.

FIGURE 6. Expression of a constitutively active PAK1 (PAK1S233E) bypasses the requirement for
PI3K in EGF-induced PAK1 activation. PC3 cells were incubated and treated with EGF and LY294002
as described above (Fig. 4). A, Whole-cell lysates of PC3 cells were blotted with antibodies to the
indicated proteins. AKT phosphorylation at S473 (AKTS473) was used as an indicator of PI3K activation.
B, Colocalization of phospho-PAK1S223 and phospho-p41-ArcT21 in PC3 cells. C, PC3 cells expressing
GFP-PAK1 or GFP-PAK1S223E were costained with anti-phospho-p41-ArcT21 and anti-phosphoPAK1S223antibodies. D, Whole-cell lysates of PC3 cells expressing GFP-PAK1 or GFP-PAK1S223E were
blotted with antibodies against the indicated proteins. E, Wound healing assay of PC3 cells expressing
PAK1 or GFP-PAK1S223E. The results were expressed as the percentages of the remaining area as
determined by normalizing the area of wound after 24 h (black bars) to the initial wound area at 0 h
(white bars, set to 100%) (left). Each bar represents the mean ± s.e of five fields counted (***, P<0.001)
(right). DNA was stained with DAPI in B and C.
FIGURE 7. CKIP-1 is required for PAK1-mediated malignant transformation of the benign
prostate RWPE-1 cells. A, RWPE-1 cells (shNT and shCKIP-1) expressing GFP-PAK1 were incubated
in serum-containing medium and stained with rhodamine-labeled phalloidin. DNA was stained with
DAPI (blue). B, Whole-cell lysates of RWPE-1 cells expressing GFP-PAK1 were blotted with antibodies
to the indicated proteins. C, Invasion assay of RWPE-1 cells expressing GFP-PAK1. Cell invasiveness
was assessed using a Transwell Boyden chamber assay (top), and the invasion rate was determined as
described in Fig. 3G (bottom). D, Anchorage-independent growth assay of RWPE-1 cells (shNT and
shCKIP-1) expressing GFP-PAK1. GFP-PAK1-induced shNT or shCKIP-1 cells were visualized by
phase-contrast microscopy (top). Quantitative analysis of colony numbers (mean ± SD) in week 3 is
shown (n = 4) (bottom). **, p < 0.05 (as compared with control).
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FIGURE 5. PI3K regulates the interaction of PAK1 with CK2α and CKIP-1. PC3 cells were
incubated and treated with EGF and LY294002 as described above (Fig. 4). A, Western blot analysis of
the interaction of PAK1 with CK2α and CKIP-1. GFP-PAK1 expressed in PC3 cells (- LY and + LY)
was immunoprecipitated using anti-GFP antibody (IP) and blotted with anti-GFP, anti-CK2α or antiCKIP-1 antibody (IB). B, PC3 cells were costained with anti-CKIP-1 (green) and anti-CK2α (red)
antibodies. C and D, PC3 cells were costained with anti-PAK1 antibody (red) and either anti-CKIP-1
antibody (green) (C) or anti-CK2α antibody (green) (D). DNA was stained with DAPI in B, C and D.

PI3K Regulation of PAK1

Downloaded from http://www.jbc.org/ at GWU Himmelfarb Library on July 10, 2015

14

PI3K Regulation of PAK1

Downloaded from http://www.jbc.org/ at GWU Himmelfarb Library on July 10, 2015

15

PI3K Regulation of PAK1

Downloaded from http://www.jbc.org/ at GWU Himmelfarb Library on July 10, 2015

16

PI3K Regulation of PAK1

Downloaded from http://www.jbc.org/ at GWU Himmelfarb Library on July 10, 2015

17

PI3K Regulation of PAK1

Downloaded from http://www.jbc.org/ at GWU Himmelfarb Library on July 10, 2015

18

PI3K Regulation of PAK1

Downloaded from http://www.jbc.org/ at GWU Himmelfarb Library on July 10, 2015

19

PI3K Regulation of PAK1

Downloaded from http://www.jbc.org/ at GWU Himmelfarb Library on July 10, 2015

20

Cell Biology:
The Role of the Pleckstrin Homology
Domain-Containing Protein CKIP-1 in
Activation of p21-activated Kinase 1
(PAK1)
Yong Bae Kim, Yong Jae Shin, Adhiraj Roy
and Jeong-Ho Kim
J. Biol. Chem. published online July 9, 2015

Find articles, minireviews, Reflections and Classics on similar topics on the JBC Affinity Sites.
Alerts:
• When this article is cited
• When a correction for this article is posted
Click here to choose from all of JBC's e-mail alerts
This article cites 0 references, 0 of which can be accessed free at
http://www.jbc.org/content/early/2015/07/09/jbc.M115.675124.full.html#ref-list-1

Downloaded from http://www.jbc.org/ at GWU Himmelfarb Library on July 10, 2015

Access the most updated version of this article at doi: 10.1074/jbc.M115.675124

